<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02960256</url>
  </required_header>
  <id_info>
    <org_study_id>112-16</org_study_id>
    <nct_id>NCT02960256</nct_id>
  </id_info>
  <brief_title>The Impact of Infectious Disease on QT Segment</brief_title>
  <official_title>The Impact of Infectious Disease on QT Segment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>HaEmek Medical Center, Israel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>HaEmek Medical Center, Israel</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Sepsis related to the development of cardiac complications. However, the investigators&#xD;
      understanding regarding this condition remains incomplete. Possible explanations raised&#xD;
      include coronary perfusion decrease, activation of the coagulation system and release of&#xD;
      inflammatory mediators, including endotoxins, cytokines and others.&#xD;
&#xD;
      In this study the investigators wanted to examine the impact of any infectious disease, (not&#xD;
      necessarily Pneumonia), on the QT interval in patients hospitalized for acute infectious&#xD;
      disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">December 2016</start_date>
  <completion_date type="Actual">March 2017</completion_date>
  <primary_completion_date type="Actual">March 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prolongation of the QT</measure>
    <time_frame>5 days</time_frame>
    <description>QT will be measured by ECG</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">169</enrollment>
  <condition>Sepsis</condition>
  <condition>Pneumonia</condition>
  <condition>Cardiomyopathy, Secondary</condition>
  <arm_group>
    <arm_group_label>Patients admitted to an internal medicine department due to an</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ekocardiogram test</intervention_name>
    <description>ekocardiogram test</description>
    <arm_group_label>Patients admitted to an internal medicine department due to an</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients admitted to an internal medicine department due to an infectious disease.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Internal ward hospitalized patient, due to illness which its etiology is bacterial,&#xD;
             fungal or viral&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Can not technically perform reliably ECG (amputated legs, lack of cooperation, etc.)&#xD;
&#xD;
          -  Subject with permanent pacemaker&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Haemek Medical Center</name>
      <address>
        <city>Afula</city>
        <country>Israel</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Israel</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <study_first_submitted>November 2, 2016</study_first_submitted>
  <study_first_submitted_qc>November 8, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 9, 2016</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 14, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>HaEmek Medical Center, Israel</investigator_affiliation>
    <investigator_full_name>Lee Goldstein</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Infections</mesh_term>
    <mesh_term>Cardiomyopathies</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

